<!–
By Sudinfo with Bloomberg
| Published on 3/24/2021 10:47 AM––
A stockpile of some 29 million doses of the Covid-19 vaccine from the pharmaceutical firm AstraZeneca is in a factory of the Catalent company in Anagni, Italy, the Italian newspaper La Stampa wrote on Wednesday. According to the daily, it would be a stock intended for export to the United Kingdom, which was discovered by the Italian authorities after a report from the European Commission.
********* ********** **** ** ****** ********* **** *** **** ** ******* ** ******* **** ********* *** *********** ***** ******* ***** ***** ** ******* ** ********** **** ******* ******** ***** ******** ** **** ** **** ** ******* ******* ************** ******* ****** **** *** ********** *** ***** *********** *** ** ******* **** *********** ***** ********** ** ************** ****** ***** *** ****** ************
** ******* ******* ****** *** ***** ************* ** ****** ****** ***** ******** ***** ** ******* ** ********* ***** *** ******** *** ******** ** ************* **** ****** *********** *** ******** ********* ************* ******* ** ******** **************** *** ******** ********** *********** *** ************* *** ****** ** ***** ** ** ***** *** *********** **** ******* *** ******** ************ ****** ******* *** **** ********* **** ******* **** ** ******* ** ***** ****** ************* *** ********** *************** ** ****** ******** *************** *** ** **** ** ********** ****** ** ** ***** ****************** ** ***** ** ****** ******** ******* ** ** *** ** ******* ******** ********* ** ******* ******** ***** ** ********** *********** ** *************** ** ***** ***** ****** *** ****** ************ *** **** ************ **** ** ******* ********* **** ** ******* *********** *** ** ************
**** ** ***** ** ** ******** ** ********** ***** ******* ** ** ****** *** ******** ** ********** ** ************ ** **************** *** ************ ** ******* ** ********** ******* ****** ******* ******* *** ***** ******** *************** * ***** ********* ** ************ ******* ******** **************** *** ******* *********** ********** **** ************* ******* ******* ******
** ********** * ****** ***** ********* *** ***** ** ************* ********* **** ******* ** ******** *** ******** ******** **** ******** ** ** ********* *** ************* ************ *** *********** *** ****** ** ****** ********* ******** **** ** ******** ******* *** ******* *** *** **** ******* ************* ******* **********
************ ***** ** ******* ** ** *** *** ************ ********** ***** *********** ****** ****** ** ** ********** *** *********** ********** ******** ** ***** *********** *** ********** **** ** *******
— .
